The Pharma Data

JUNE 18, 2021

June 8, 2021 /PRNewswire/ — Allergan Aesthetics, an AbbVie company (NYSE: ABBV ), is changing the way BOTOX ® Cosmetic, the #1 selling neurotoxin treatment 1 , is connecting with consumers. “BOTOX ® Cosmetic is honoring and celebrating the dynamic people who use our products. IRVINE, Calif.

Botox 52

Botox Cosmetics Doctors Doctor 52

XTalks

JUNE 17, 2024

Hugel, a Korean medical aesthetics company, recently announced that it has received marketing approval from the US Food and Drug Administration (FDA) for its botulinum toxin, Letybo (letibotulinumtoxinA-wlbg), for the treatment of glabellar lines. We are thrilled with the FDA’s approval of Letybo. What Is the Price of Letybo?

FDA Approval 52

FDA Approval Marketing Botox Clinical Trials 52

XTalks

NOVEMBER 1, 2024

The neurology drug market continues to be dynamic with novel treatments that cater to a broad range of neurological and psychiatric conditions. In 2024, several blockbuster neurology medications are set to lead the market, capturing the attention of healthcare professionals, investors and patients alike. as of January 2024.

FDA Approval 85

FDA Approval Drugs Botox Sales 85

Roots Analysis

JANUARY 29, 2024

The treatments / products provided by medical aesthetics companies used for facial aesthetic procedures have been mentioned below: Botulinum toxin: It is a toxin produced by a bacterium, Clostridium botulinum , commonly referred to as Botox. Tattoo Removal: It is a cosmetic procedure that involves removing ink from the top layer of the skin.

Filler 40

Filler Cosmetics Botox Marketing 40

The Pharma Data

AUGUST 1, 2021

Global Botox Therapeutic net revenues were $603 million, an increase of over 100.0 Global Botox Cosmetic net revenues were $584 million, an increase of over 100.0 The FDA cited its ongoing review of Pfizer’s post-marketing study, ORAL Surveillance, evaluating tofacitinib in patients with rheumatoid arthritis (RA).

Botox 52

Botox Cosmetics Trials Clinical Trials 52

The Pharma Data

FEBRUARY 4, 2021

– Full-Year Global Net Revenues from the Aesthetics Portfolio Were $2.590 Billion; Global Botox Cosmetic Net Revenues Were $1.112 Billion. Global Botox Cosmetic net revenues were $493 million , an increase of 9.1 Global Botox Therapeutic net revenues were $567 million , a decrease of 1.0 Recorded a $4.7

Botox 52

Botox Production Sales Cosmetics 52

Roots Analysis

JANUARY 3, 2024

Medical aesthetics is a growing area of modern medicine that focuses on improving the cosmetic appearance of an individual through various medical treatments. However, Botulinum toxin was the real game-changer when it was approved for cosmetic use by the FDA in 2002.

Filler 40

Filler Cosmetics Production Dermatology 40